Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Optimizing the Integration of Mobile and Patient-Facing Tech in Clinical Trials
|
May 02, 2024 |
Delivering Exceptional Clinical Trial Experiences for Patients
|
May 02, 2024 |
ctDNA Potential for Prognostic Stratification, Tumor Insights & Drug Development
|
May 01, 2024 |
What to Expect at the 2024 Patients as Partners EU Conference
|
Apr 23, 2024 |
Taking Lessons from Manufacturing Immunotherapies to Accelerate Development
|
Apr 12, 2024 |
Enhancing Solubility with Novel Excipient Technologies
|
Apr 08, 2024 |
Measuring the Value of DCTs and Hybrid Models
|
Apr 02, 2024 |
Navigating and Adopting Innovation in a Post- Pandemic World
|
Mar 29, 2024 |
Turning a Search for Lung Cancer Biomarkers into a Patient Empowerment Community
|
Mar 15, 2024 |
Engaging All Stakeholders for Clinical Trial Patient Engagement and Value
|
Mar 12, 2024 |
Optimizing Medicine Development for Real-World Efficacy in Patients
|
Feb 26, 2024 |
Prioritizing Development Programs that Align with Fundraising Catalysts
|
Jan 30, 2024 |
How CMOs can Support the Overarching Process of a Fundraising
|
Jan 30, 2024 |
Interacting with Different Types of Investors as a CMO
|
Jan 29, 2024 |
Developing Internal and External Communication Strategies
|
Jan 29, 2024 |
What CMOs Need to Know About Medical Affairs
|
Jan 28, 2024 |
Achieving Targeted Delivery of Gene Editing Therapies
|
Jan 09, 2024 |
The Promise and Challenges of Ultrasound-Mediated Delivery
|
Jan 09, 2024 |
New Approaches in CNS/PNS Delivery
|
Jan 08, 2024 |
The Future of Digital Technology in the Connected Device Space
|
Jan 08, 2024 |
Precision Ophthalmic Delivery
|
Jan 07, 2024 |
Delivery Challenges from the Oncology Pipeline
|
Jan 07, 2024 |
Overcoming Barriers to Adoption of Transdermal Delivery
|
Jan 04, 2024 |
Novel Nasal Products and Formulations
|
Jan 04, 2024 |
Addressing the Clinical Operations Workforce Gap
|
Dec 20, 2023 |
Evolving US Clinical Trial Infrastructure for Better Trials & Emergency Response
|
Dec 20, 2023 |
Community Organization Perspectives on Improving Clinical Trial Initiatives
|
Dec 14, 2023 |
Patients on How R&D Organizations Can Better Operationalize Trials for Patients
|
Dec 14, 2023 |
Novartis’ Approach to Making Patients Feel Valued in Clinical Research
|
Oct 26, 2023 |
How Henry Ford Health Integrated Clinical Trials into Clinical Care
|
Oct 26, 2023 |
Reimbursement Challenges with Clinical Trials
|
Oct 25, 2023 |
Democratizing Access: Enabling All Care Locations to be Research Locations
|
Oct 25, 2023 |
Strategies for Building a Successful Clinical Research Team in the Care Setting
|
Oct 24, 2023 |
How to Optimize Inventory and Sample Management for Clinical Trial Health
|
Oct 04, 2023 |
Ensuring That Sites Are Set Up for Trial Success, Using Data and Technology
|
Aug 29, 2023 |
Innovating Patient Recruitment: A Conversation with BBK Worldwide Founders
|
Aug 07, 2023 |
10th Annual Mobile Tech in Clinical Trials: What to Expect in under 10 Minutes
|
Jul 28, 2023 |
CRAACO Director's Note Podcast on What to Expect in Under 6 Minutes
|
May 10, 2023 |
Current Challenges in Vaccine Delivery and Distribution
|
Jan 23, 2023 |
Providing the Right Level of Value to the Patient that Creates Value
|
Jan 20, 2023 |
Enhancing the Interferon Pathway to Attack Cancer
|
Jan 19, 2023 |
Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies
|
Jan 18, 2023 |
Investment Trends in IO
|
Jan 17, 2023 |
Investment and Collaboration Strategies in Cell and Gene Therapy
|
Jan 16, 2023 |
Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors
|
Jan 14, 2023 |
Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
|
Jan 13, 2023 |
Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.
|
Jan 12, 2023 |
Panel: Targeted Radiotherapy and the Impact on IO
|
Jan 11, 2023 |
What’s Next on the IO Radar? Top 10 Recommendations from Dr Andrew Baum, Citi
|
Jan 10, 2023 |
KEYNOTE FIRESIDE CHAT with Dr Robert Langer and Dr Ester Caffarel-Salvador
|
Jan 10, 2023 |
Panel: Role of China in the BD Process
|
Jan 09, 2023 |
Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic
|
Jan 06, 2023 |
How Janssen is Collaboratively Working with Patients and Sites to Advance DCTs
|
Jan 05, 2023 |
How Merck is Partnering with Communities to Support Clinical Research
|
Jan 04, 2023 |
Sanofi’s New Initiatives Firmly Embedding Patient Experience & Perspectives
|
Jan 03, 2023 |
Reflections on Alnylam and Conquering Delivery
|
Jan 03, 2023 |
Patient Involvement Legal Barriers to Be Aware of and Pathways to Overcome Them
|
Jan 02, 2023 |
Next Generation Immune Checkpoints: Deciphering Key Roles in the TME
|
Jan 02, 2023 |
Merck Reporting on Site Monitoring, Performance and Database Lock
|
Dec 31, 2022 |
The Role of RWD in the Development of Remdesivir
|
Dec 30, 2022 |
De-risking Combination Product Development Involving L Volume Sub Formulations
|
Dec 30, 2022 |
How Regeneron Got an FDA Approved Therapy for COVID in Record Time
|
Dec 29, 2022 |
Remote Monitoring to Improve Transitioning Home and Reducing Risk of Readmission
|
Dec 28, 2022 |
The Pfizer Pledge: Getting to 60% Remote Clinical Trials in 2022
|
Dec 27, 2022 |
Benchmarking Clinical Operations for Digital Maturity
|
Dec 26, 2022 |
Innovative Trial Designs to Reduce Patient, Site and Investigator Burden
|
Dec 23, 2022 |
Addressing the Lack of Structured, Clean Patient Data
|
Dec 22, 2022 |
Fireside Leadership Lessons: Driving Innovation to Support Patients and Sites
|
Dec 21, 2022 |
Why Rare Disease Therapeutics Need Early Market Access Planning
|
Dec 21, 2022 |
Effective Concentration for a Longer Period with Long Acting Injectables
|
Dec 20, 2022 |
Moderna on Innovating Clinical Trial Partnerships to Expand Access
|
Dec 20, 2022 |
Regeneron and Novartis on Innovating to Accommodate Growing Pipelines
|
Dec 19, 2022 |
Development of the Lipid Nanoparticles
|
Dec 19, 2022 |
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
|
Dec 14, 2022 |
Biomarkers in IO: Challenges and Putative Benefits of Multi-omics Technologies
|
Dec 12, 2022 |
Chair’s Opening Presentation with Barbara Lueckel Summary
|
Dec 12, 2022 |
A Decade After Checkpoints- What Do We Know, What Do We Need to Know and Getting
|
Dec 08, 2022 |
Achieving Diversity and Inclusion in Oncology Clinical Trials
|
Dec 07, 2022 |
How Long-Acting Implantables Are Taking Extended Drug Release to the Next Level
|
Dec 07, 2022 |
Advancements in CART for the Treatment of Glioblastoma
|
Dec 06, 2022 |
From Carer to Trailblazer: One Man’s Fight to Impact Clinical Research
|
Dec 06, 2022 |
Cell & Gene Therapy: Current Landscape, Lessons Learned and Paths Forward
|
Dec 05, 2022 |
What to Expect at the IO360° Summit in 6 Minutes
|
Dec 05, 2022 |
Solving for the Digital Divide: Building Trust with Mobile Tech for Patients
|
Dec 02, 2022 |
How Moderna Built a Digital Organization to Transform How Clinical Research Gets
|
Dec 01, 2022 |
Roche’s Industry Overview on the Drug Delivery Landscape 2022
|
Nov 30, 2022 |
Leveraging Mobile Technologies in the Development of Novel Digital Endpoints
|
Nov 30, 2022 |
How Mobile Tech is Enabling Smarter Trial Designs for Better Data and Access
|
Nov 29, 2022 |
FDA Update on Digital Health Technologies in Clinical Trials Draft Guidance
|
Nov 28, 2022 |
Taking Patient Involvement in Clinical Publications to New Heights
|
Nov 28, 2022 |
Partnering with Your Compliance Teams to Advance Meaningful Collaboration
|
Nov 21, 2022 |
What Statisticians Wish They Could Tell Their Chief Medical Officers
|
Nov 17, 2022 |
Tackling the Manufacturing Complexity of Complex to Deliver Pipelines
|
Nov 16, 2022 |
Misaligned Incentives: Physician Perspectives on the Integration of CRAACO
|
Nov 16, 2022 |
Rewriting the Way We Work Together to Integrate Clinical Care and Research
|
Nov 15, 2022 |
Volunteering for a Vaccine Trial, Tackling Racial Disparities in Healthcare
|
Nov 14, 2022 |
How Amgen is RISING Above with Clinical Trial Diversity
|
Nov 14, 2022 |
A Vision for the Integration of Clinical Research and Care
|
Nov 11, 2022 |
Addressing Barriers to Patient Community Access through Non-Profit Partnerships
|
Nov 10, 2022 |
Educating Patients and Non-Research Physicians on Navigating Clinical Research
|
Nov 09, 2022 |
Long Acting Injectables for Biologics
|
Nov 09, 2022 |
Where and How DCTs Can Truly Enable and Close the Gaps between Research and Care
|
Nov 08, 2022 |
Partnering with Health Systems to Enhance Diverse Patient Access in Trials
|
Nov 07, 2022 |
Novartis’ Approach to Patient Engagement
|
Nov 07, 2022 |
Workforce Planning & Reducing Churn to Support and Promote CRAACO
|
Nov 04, 2022 |
Guest Keynote Connecting Communities with the CEO of Etsy
|
Nov 03, 2022 |
Making Institutional Change to Offer Clinical Research Options in Health Systems
|
Nov 02, 2022 |
Microgravity to Develop Crystalline Monoclonal Antibodies for Subcutaneous
|
Nov 02, 2022 |
CMO-CEO Fireside Discussion on Working Through Challenges
|
Nov 01, 2022 |
Building Trust to Ensure Diversity, Equity, Inclusion in Clinical Research
|
Oct 31, 2022 |
Drug Delivery Pipeline and Technologies, a Year in Review
|
Oct 26, 2022 |
How Eli Lilly is Diversifying and Engaging Patients Using DCT Capabilities
|
Oct 24, 2022 |
Advice for Partnering Between Innovator Drug Delivery Companies and Big Pharma
|
Oct 19, 2022 |
Fighting to be a True Stakeholder in Clinical Care and the Impact on Diversity
|
Oct 17, 2022 |
The First 90 Days as a CMO
|
Oct 14, 2022 |
R&D Veteran on Leading a Biotech through Founding, IPO and Acquisition
|
Oct 14, 2022 |
Building up a Company Through to Commercialization and Beyond
|
Oct 13, 2022 |
Best Practices for Cross Functional Communication Strategies for the CMO
|
Oct 12, 2022 |
Nicholas Warne Drug Delivery Industry
|
Oct 12, 2022 |
Managing the Partnership Between Big and Small Pharma
|
Oct 10, 2022 |
Infusing Patient Perspectives Across All of Pfizer
|
Oct 10, 2022 |
The Changing Environment Around Accelerated Approvals and Regulatory Pathways
|
Oct 07, 2022 |
Biotech Financing Options and Their Implications
|
Oct 06, 2022 |
Positioning Yourself For Board Roles and What to Expect as a CMO in Biotech
|
Oct 06, 2022 |
Building a Work Culture that Attracts and Retains Talent in Biotech
|
Oct 05, 2022 |
Exploring Ways to Reduce Costs of Developing & Manufacturing Drug Delivery Tech
|
Oct 05, 2022 |
Taking on the CMO Role at Moderna and Looking to the Future of Biotech R&D
|
Oct 04, 2022 |
What CMOs Must Know About How Patient Engagement Supports the Entire Biotech
|
Oct 03, 2022 |
Operationalizing the Integration of Patient Insights
|
Oct 03, 2022 |
How Sites Using Their Own Technology for Research Benefits All Stakeholders
|
Sep 29, 2022 |
Adjusting Your eCOA Strategy For Patient Centricity: Expert Advice
|
Sep 26, 2022 |
Sandoz's Chief Operating Officer Discusses the New Initiative Act4Biosimilars
|
Aug 31, 2022 |
A Natural Language Collaboration That Helps Cancer Patients Navigate Treatment
|
Aug 31, 2022 |
12th Annual DPHARM in Under 10 Minutes
|
Aug 06, 2022 |
Director's Notes on What to Expect at CRAACO: Clinical Research as a Care Option
|
Aug 04, 2022 |
What to Expect at Mobile Tech in Clinical Trials 2022
|
Aug 02, 2022 |
5 Minute Overview Podcast on What to Expect at PODD: Drug Delivery
|
Jul 19, 2022 |
Key Role of Strategy and Media in Improving Clinical Trial Enrollment Diversity
|
May 19, 2022 |
How CMOs Can Evaluate Potential Outsourcing Partners Effectively
|
May 02, 2022 |
Is the End of SDTM in Sight?
|
May 02, 2022 |
What Adapting During COVID-19 Taught Us About Innovating Drug Development
|
Apr 27, 2022 |
A Vision for the Future of Drug Delivery: Patients Interacting Less with Disease
|
Apr 15, 2022 |
How Listening Tech Disrupts Clinical Research to Create Patient-Centric Trials
|
Apr 14, 2022 |
On-the-Ground Perspective on Putting Decentralized Strategies in Clinical Trials
|
Apr 14, 2022 |
Biotech CEO Keynote, Dr Ron Cohen, from Chief Medical Officer Summit 360° 2021
|
Feb 17, 2022 |
R&D Veteran Keynote, Dr Jo Viney, from Chief Medical Officer Summit 360° 2021
|
Feb 17, 2022 |
10th Annual Chief Medical Officer Summit 360º in a Nutshell
|
Feb 15, 2022 |
The Case for Sites Using Their Own Tech to Accelerate Research and Reduce Burden
|
Jan 20, 2022 |
5 Talks to Watch (and Why) at IO360º 2022 with Strategic Advisor Dr Dan Chen
|
Jan 18, 2022 |
8th Annual Immuno-Oncology 360° Summit: What to Expect in 7 Minutes
|
Jan 02, 2022 |
Patients as Partners EU 2022 in 5 Minutes
|
Dec 17, 2021 |
How Artificial Intelligence Is Creating Better Clinical Trials, with Saama
|
Dec 03, 2021 |
Making the Leap from IV to Subcutaneous, with Halozyme's ENHANZE® Technology
|
Nov 23, 2021 |
J&J Vision on Progress in Eyecare and Meeting the Needs of Future Patients
|
Oct 21, 2021 |
Flexible Data Collection and Best DCT Strategies: Advice from an Expert
|
Oct 18, 2021 |
Building a Successful Relationship with your Development Partner
|
Oct 05, 2021 |
9th Annual Chief Medical Officer Summit 360° Overview in 5 Minutes
|
Aug 27, 2021 |
10 Year Review on Drug Delivery
|
Aug 17, 2021 |
8th annual Mobile in Clinical Trials in 5 Minutes
|
Aug 04, 2021 |
PODD 2021 in 7 Minutes with Director, Valerie Bowling
|
Jul 27, 2021 |
Ferring on Creating a First-in-Class Microbiome-Based Therapeutic
|
Jul 19, 2021 |
DPHARM in 10 Minutes with Director Valerie Bowling
|
Jul 12, 2021 |
The Biotech Incubator Helping Entrepreneurs Launch Companies to Advance Health
|
Jul 07, 2021 |
How and When to Pursue Decentralized Clinical Trials: Conversation with Experts
|
Jun 15, 2021 |
How to Utilize Technology to Truly Increase Diversity in Clinical Trials
|
Apr 15, 2021 |
Insights from CRAACO 2020 and Looking to the Future
|
Apr 09, 2021 |
The Practical Implementation of Sensors in the Changing Drug Development World
|
Jan 22, 2021 |
Patients as Partners Europe 2021 Overview in 5 Minutes
|
Jan 11, 2021 |
Innovations & Novel Approaches in IO Imaging & Assessing Responses
|
Dec 27, 2020 |
HLA Loss and the Impact on Immunotherapy
|
Dec 27, 2020 |
Cell & Gene Therapy Debate: Intrinsic Editing vs Systemic Combination
|
Dec 27, 2020 |
Operational Dynamics of Implementing & Managing Basket Trials
|
Dec 27, 2020 |
Overcoming Site Regulatory Issues to Optimize Clinical Quality
|
Dec 11, 2020 |
Evolution of Regulatory Policy For Cell/Gene Therapy
|
Nov 03, 2020 |
Centralized vs Decentralized Manufacturing
|
Nov 03, 2020 |
Next Generation Bispecifics in Solid Tumors
|
Nov 02, 2020 |
Ariella Chivil's Immunotherapy Trial Pathway
|
Nov 02, 2020 |
Insitu Vaccinations vs Systemic Neo-Epitope Vaccinations
|
Oct 30, 2020 |
What Do Next Generation of Immunotherapies Need to Look Like to Move the Needle?
|
Oct 30, 2020 |
Using Sensor Technology to Deploy Decentralized Trials and Improve Patient Care
|
Oct 29, 2020 |
Current Issues and Potential Solutions for Site Audit Readiness and Monitoring
|
Oct 26, 2020 |
5 Minute Overview of 8th Annual CMO Summit 360º
|
Oct 19, 2020 |
The Future of Clinical Research and the Innovation from the COVID-19 Pandemic
|
Oct 07, 2020 |
Connecting Care and Research for the Patient with a Decentralized Trial Model
|
Sep 30, 2020 |
Remote Monitoring for Clinical Research in the Digital Age
|
Sep 18, 2020 |
Solving for the Patient Retention Problem in Clinical Research
|
Sep 09, 2020 |
IO Combinations 360° Overview in 7 Minutes
|
Sep 08, 2020 |
Enabling Clinical Trial Continuity with Live Video Visits
|
Sep 08, 2020 |
Roche's Dr Barbara Lueckel's Opening Remarks and the 2018 Year in Review
|
Aug 26, 2020 |
How a Gene Therapy for Duchenne Muscular Dystrophy Came to Be
|
Aug 25, 2020 |
How a Covid-19 Research Study was Formed with Oracle, Javara and Wake Forest
|
Jul 27, 2020 |
IO Biomarker Discovery & Personalized Cancer Therapy Development with Personalis
|
Jun 19, 2020 |
The Impact of COVID-19 on Clinical Trials: Where are We? And Where are We Going?
|
Jun 18, 2020 |
7th Annual Mobile in Clinical Trials Overview in Under 5 Minutes
|
Jun 18, 2020 |
KPIs that Support Innovation for Patient-Engagement
|
May 10, 2020 |
Starbucks: Innovation for the End User Experience
|
May 09, 2020 |
Transparency and the Future of Patient Expectations
|
May 09, 2020 |
Turning Genes into Medicines: Gene Therapy for Genetic Disease
|
May 08, 2020 |
Formulation & Device Lifecycle Management for Biotherapeutics
|
May 08, 2020 |
Future Outlook for Novel Drug Delivery
|
May 07, 2020 |
Modality Fluid Development: Evolving Pipelines and Drug Delivery Solutions
|
May 07, 2020 |
MedTech Fireside Chat: The Journey of an Emerging Medical Device Company
|
May 06, 2020 |
Case Study: Forming and Managing a Drug Delivery Alliance
|
May 06, 2020 |
Supporting Business Models for Scaled Connected Health Drug Delivery Products
|
May 05, 2020 |
Utilizing Digital Health Data to Improve Management, Prevention & Wellness
|
May 05, 2020 |
Understanding Jansen's Metaphyseal Chondrodysplasia
|
May 05, 2020 |
The Collective Struggle to Evolve Data and Analytics Culture & Capabilities
|
May 04, 2020 |
Re-Thinking Clinical Development - Using Historical Data to Transform Trials
|
May 04, 2020 |
The Evolution of Using Real World Data to Create Trial Readiness Cohorts
|
May 03, 2020 |
The PD-FIDI: Developing a Digital Endpoint for Parkinson's Disease
|
May 03, 2020 |
Planning For and Addressing Missing Data in Mobile Clinical Trials
|
May 02, 2020 |
Balancing Innovation with Solid Common Sense to Deliver Innovative Medicines
|
May 02, 2020 |
Virtual Trials: What are We Striving for and Measurements of Success
|
May 01, 2020 |
Escaping Pilotville: How to Scale Mobile / Digital Deployment in Clinical Trials
|
May 01, 2020 |
Merck's Strategy to Mobilize Mobile Efforts and Engineer for Scale
|
Apr 30, 2020 |
What Does a Successful Digital Trial Look Like?
|
Apr 30, 2020 |
Advocating for People Managing Hermansky-Pudlak Syndrome
|
Apr 29, 2020 |
Maintaining Clinical Trial Patient Engagement in COVID with Be the Partner
|
Apr 29, 2020 |
Setting Up Therapeutic + Vaccine Programs for COVID-19: Lessons Learned
|
Apr 28, 2020 |
Understanding Spinal Muscular Atrophy: A Chief Scientific Officer's Perspective
|
Apr 14, 2020 |
Changing How We Treat Systemic Sclerosis
|
Mar 19, 2020 |
New Opportunities for Cell Therapy Combinations
|
Mar 10, 2020 |
PD1 Resistance with a Multi-Omic Approach
|
Mar 10, 2020 |
Updates on PARP Inhibition
|
Mar 09, 2020 |
Leveraging the Tumor Microenvironment for IO Therapy
|
Mar 08, 2020 |
Updates on Bintrafusp alfa/M7824 Clinical Data
|
Mar 07, 2020 |
NKTR-214: Harnessing the IL-2 Pathway in Combination Immunotherapies
|
Mar 06, 2020 |
Advancing Bispecifics for Combination Immunotherapy
|
Mar 02, 2020 |
How AI, Machine Learning and Big Data are Used to Inform Combinations
|
Mar 01, 2020 |
Weighing Your Options in Considering Clinical Trials from a Patient Perspective
|
Feb 20, 2020 |
Understanding the Goals of Care vs Research
|
Feb 19, 2020 |
6 Min Podcast on What to Expect at the 7th Annual Patients as Partners
|
Feb 18, 2020 |
How to Integrate Industry Sponsored Clinical Trials Into Your Health System
|
Feb 18, 2020 |
How Sanford Health Systems Increased Clinical Trial Participation to 10%
|
Feb 17, 2020 |
Keynote: Surgeon’s Perspective on Integrating Clinical Care & Clinical Research
|
Feb 14, 2020 |
How Wilmington Health is Streamlining Integration of Clinical Research & Care
|
Feb 13, 2020 |
Addressing Barriers Health Systems Face in Integrating Clinical Care & Research
|
Feb 12, 2020 |
Effectively Democratizing Access to Clinical Trials for All
|
Feb 11, 2020 |
Delivering an Innovative, Patient-Centric Delivery System
|
Feb 06, 2020 |
Ophthalmology: Exploring Other Routes of Administration
|
Feb 06, 2020 |
Transforming Cardiovascular Treatment with Pulmonary Delivery
|
Feb 05, 2020 |
MRI-Guided Focused Ultrasound and the Delivery of Therapeutics to the Brain
|
Feb 05, 2020 |
Better Strategies to Inform Patients on Clinical Research & Trial Participation
|
Jan 23, 2020 |
Chief Patient Advocate/Officer: Driving Culture Change from the Top Down
|
Jan 23, 2020 |
How Novartis Includes Patient Input into All Aspects of a Clinical Study
|
Jan 22, 2020 |
Patients as Partners in Clinical Research EU 5 Min Upcoming Conf Summary
|
Jan 06, 2020 |
Partnering with Patients on Clinical Development Protocols
|
Dec 20, 2019 |
Improving Clinical Research and Trials Through Pharma/Advocacy Partnerships
|
Dec 19, 2019 |
Engaging with Communities to Educate and Enroll Diverse Populations
|
Dec 19, 2019 |
Mapping Out the Patient Decision Journey
|
Dec 18, 2019 |
FDA Patient Engagement Synergistic Efforts
|
Dec 17, 2019 |
The Democratization of Patient Data Ownership: Returning Results
|
Dec 16, 2019 |
Cell & Gene Therapy Day Overview in 4 minutes
|
Dec 04, 2019 |
2020 Immuno-Oncology 360° Summit Overview in 10 Minutes
|
Dec 04, 2019 |
Fireside Chat with an R&D Veteran
|
Dec 03, 2019 |
Designing Clinical Trials for Gene Therapy - A Paradigm Shift
|
Dec 03, 2019 |
Case Study: Life of a Chief Medical Officer Pre and Post IPO
|
Dec 02, 2019 |
How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval
|
Dec 02, 2019 |
Addressing the Talent Gap in Biotech - Recruit and Retain
|
Dec 02, 2019 |
How to Navigate the Development Path from CMO to CEO
|
Dec 01, 2019 |
How do Patients Become Partners in the Sharing of Data to Advance Science?
|
Nov 06, 2019 |
Best Practices for Pharma - Patient Advocacy Partnerships
|
Nov 05, 2019 |
Merck's Next Phase of Patient Centricity in R&D
|
Nov 04, 2019 |
Clinical update on AMG 420, an anti-BCMA BiTE®
|
Nov 01, 2019 |
Connecting Employee-Centric Culture to Patient-Centric Culture
|
Nov 01, 2019 |
Eliciting Patient Experience Data to Understand Medicines Benefits/Disadvantages
|
Oct 31, 2019 |
Understanding the Language of Patients - The Value of Health Literacy
|
Oct 30, 2019 |
UCB and Parkinson's UK Collaboration Improve a Trial through Patient Involvement
|
Oct 29, 2019 |
Improving T Cell Therapies via Next Generation Technologies
|
Oct 17, 2019 |
Monetizing Science: Turning an Asset into Value through IPOs
|
Oct 16, 2019 |
IDO Changes the T-cell Balance in the Tumor Microenvironment
|
Oct 16, 2019 |
Insights from Deal Trends: Betting on Tumor Immunology
|
Aug 29, 2019 |
Living with Alzheimer’s from a Young Patient's Perspective
|
Aug 23, 2019 |
Organizational and Digital Restructuring to Scale Mobile Clinical Trials
|
Aug 23, 2019 |
How to Align the Promise of Technology with the Patient Voice
|
Aug 22, 2019 |
The Role of Digital Biomarkers and the Impact on Drug Delivery
|
Aug 22, 2019 |
PODD: Partnership Opportunities in Drug Delivery 2019 Overview in 4 Minutes
|
Aug 20, 2019 |
A Patient Perspective on Living with Parkinson's Disease and the GDNF Trial
|
Aug 19, 2019 |
The Future of Mobile Data in Clinical Trials: Challenges and Opportunities
|
Aug 15, 2019 |
Eli Lilly: How to Launch Multiple Mobile Devices in a Hybrid Setting
|
Aug 15, 2019 |
Pfizer’s Atopic Dermatitis Clinical Trial with Digital Wearable Technology
|
Aug 08, 2019 |
Merck’s Digital Health and Al Strategy: Progress Report
|
Aug 07, 2019 |
How Digital Biomarker Innovation is Modernizing Clinical Endpoints
|
Jul 31, 2019 |
Regenerative Medicine as a Disrupter in Clinical Trials
|
Jul 30, 2019 |
6th Annual Mobile in Clinical Trials: What to Expect in 4 Minutes
|
Jul 29, 2019 |
Estonia, The Digital Republic: Where Patients Own Their Data
|
Jul 29, 2019 |
Co-Creating the Industry's Scalable Solution for EHR
|
Jul 28, 2019 |
Bringing Blockchain to Life: Digitizing Clinical Supply Chain in Trials
|
Jul 27, 2019 |
Bayer: Virtual Assistants for Sites and Patients in Clinical Trials
|
Jul 26, 2019 |
DPharm: Disruptive Innovations in Clinical Trials 2019 Overview in 5 Minutes
|
Jul 25, 2019 |
Entrepreneur Data Scientist, Ben Liu on Solving Bottlenecks in Clinical Research
|
Jul 23, 2019 |
Stories from Bioinspiration to Innovation
|
Jul 22, 2019 |
Including Wellness in the Pharma Model - How Drug Delivery will be a Key Enabler
|
Jul 21, 2019 |
Service & Patients in Clinical Trials
|
Jul 21, 2019 |
Panel: Delivering mRNA Drugs and Vaccines – Progress and Future Outlook
|
Jul 20, 2019 |
How to Innovate like Amazon to Modernize Clinical Trials
|
Jul 11, 2019 |
Alzheimer’s Studies: Exploring Registries to Improve Enrollment & Trial Design
|
Jun 25, 2019 |
4th Annual IO Combinations 360°: What to Expect in 8 Minutes
|
May 23, 2019 |
CAR-T Therapy: Optimization Through Engineering T-cells or Combinations
|
May 02, 2019 |
Combining IO Modalities In a Cost Effective, Patient Beneficial Manner
|
May 01, 2019 |